News

TriSalus Life Sciences Prepares for Q3 2024 Results Call

TriSalus Life Sciences Prepares for Q3 2024 Results Call

TriSalus Life Sciences Announces Q3 2024 Financial Results Call

TriSalus Life Sciences Inc. (NASDAQ: TLSI), a pioneering oncology company, is set to host a conference call and webcast on November 14, 2024. This event aims to discuss the company’s financial results for the third quarter that concluded on September 30, 2024, alongside a business update highlighting their innovative advancements in treating liver and pancreatic cancer.

What to Expect During the Conference Call

The conference call will commence at 9:00 a.m. ET, and interested parties can join through the investor relations section of the TriSalus website. The session promises to deliver significant insights into their latest financial results, alongside discussions about the company's progress and strategic initiatives in cancer therapies.

Following the live event, a replay will be accessible on the website for those unable to attend at the scheduled time. For participants opting to join via phone, registration through an online form will be necessary. Dial-in details will follow in an auto-generated email, ensuring easy access to the conference.

Company Overview

TriSalus Life Sciences focuses on transforming cancer treatment through innovative drug delivery methodologies. Their proprietary technology is specifically designed to enhance therapeutic delivery to tumors in the liver and pancreas. By utilizing advanced techniques, TriSalus aims to broaden the horizons of cancer treatment and improve overall patient outcomes.

The company’s offerings include two FDA-cleared devices that utilize their Pressure-Enabled Drug Delivery™ (PEDD™) technology, ensuring effective administration of therapies. Among these, the TriNav® Infusion System supports hepatic arterial infusion targeted at liver tumors, while the Pancreatic Retrograde Venous Infusion System is designed for pancreatic tumor treatment. This unique PEDD approach not only optimizes pressure and flow during delivery but also minimizes potential damage to healthy tissues, thus maximizing therapeutic efficacy.

Innovations in Immunotherapy

A key element of TriSalus's strategy involves its investigational immunotherapy, nelitolimod. This candidate aims to counteract the immunosuppressive microenvironment characteristic of many tumors. By addressing these challenges, nelitolimod seeks to enhance the effectiveness of contemporary immunotherapies, particularly in difficult-to-treat areas like the liver and pancreas. Evidence from Pressure-Enabled Regional Immuno-Oncology™ (PERIO) trials suggests that delivering nelitolimod using PEDD may yield favorable immune responses, paving the way for enhanced treatment outcomes.

Partnerships and Future Endeavors

TriSalus is committed to pushing the boundaries of cancer treatment through strategic collaborations with premier cancer centers. By leveraging their deep expertise in immuno-oncology and state-of-the-art technology development, they are actively pursuing innovative solutions that seek to elevate patient care standards across the oncology field.

As the landscape of cancer treatment evolves, TriSalus Life Sciences will continue to lead with their dedication to research and advancements in medical technology. Stakeholders and interested parties are encouraged to learn more about their groundbreaking work in improving cancer therapies through their official website.

Frequently Asked Questions

What is the main focus of TriSalus Life Sciences?

TriSalus Life Sciences specializes in oncology, particularly in enhancing drug delivery to liver and pancreatic tumors.

When will the Q3 2024 financial results call take place?

The call is scheduled for November 14, 2024, at 9:00 a.m. ET.

How can I access the replay of the conference call?

The replay will be available on the investor relations section of the TriSalus website following the live event.

What innovative technologies does TriSalus utilize?

TriSalus employs Pressure-Enabled Drug Delivery™ (PEDD™) technologies in its devices, enhancing the delivery of therapeutics to tumors.

What is nelitolimod and its role in treatment?

Nelitolimod is an investigational immunotherapy aimed at improving patient outcomes by addressing the immunosuppressive conditions in tumor environments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Choosing Screen-Free Outdoor Gifts: besrey's Top Picks

Updated Category News Views 34

The Art of Choosing Outdoor Gifts for Kids Christmas time, my friends, isn't just about plastic gimmicks and gadgets vying for kids' attention. Nope, it's about making thoughtful decisions that blend discovery, movement, and a little peace of mind for parents. This time around, besrey's got the scoop on screen-free gifts that might just do the trick—helping kids explore...

Continue Reading
Bright Idea: Menu Covers Light Up Dining Spaces

Updated Category News Views 6

Lighting Up Dinner Conversations You ever sit in a restaurant dim enough to make you question if even the chef can see in that darkness? Enter the MENU AID, a nifty brainchild straight out of Chula Vista, California. This invention brings a bright twist to our dining escapades, literally. Picture a menu cover that lights up like it's got its own little halo, solving the...

Continue Reading
AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 43

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
Navigating IRS Notices: CPA Morones' Key Steps

Updated Category News Views 73

When the IRS Knocks: Don't Panic, Get Organized Picture this, you head home after a grinding day only to find a letter from the IRS lurking in your mailbox. For taxpayers in Southwest New Mexico, as CPA Mike Morones out of Silver City puts it, the blood pressure spikes are real. But as Morones assures, most of these letters don't signal doomsday scenarios. Instead,...

Continue Reading
Morgan County, IN: An Oasis for Balanced Living

Updated Category News Views 26

Why Morgan County? A Question for Homebuyers Ever wondered what makes Morgan County, IN, such a hot ticket for folks looking to escape the daily grind of big city life? Rachel Blacklidge, real estate wizard and hometown hero, lays it all out in a way even the most city-bound among us can appreciate. Small-Town Vibes, Big-City Access Let’s face it—sometimes the chaos...

Continue Reading
B2K's Comeback with ECLIPSE Breaks Records

Updated Category News Views 194

Resurgence in the R&B World Well, if you told me B2K would make a grand return and rock the charts after 24 years, I'd have laughed. But it's happening—like a seasoned player making a comeback in overtime. The platinum-selling R&B group B2K launched a new album, 'ECLIPSE,' tied to their 'Boys 4 Life Tour.' The Innovative Marketing Strategy In a move that might just...

Continue Reading
APEC Summit 2026: Shenzhen in the Spotlight

Updated Category News Views 35

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 6

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Hollyland Powers APEC 2026 with Wireless Solutions

Updated Category News Views 56

APEC 2026 Finds a Partner in Hollyland Here's a nugget for ya: Hollyland, the pride of Shenzhen in wireless audio and video solutions, is stepping into the big leagues by becoming an official sponsor for the APEC 2026 meetings. Now that's quite the homecoming parade! Given the bustling vibes of a global conference, Hollyland’s gear will play a starring role in keeping...

Continue Reading
Student Letters Pour Gratitude Over Veterans Nationwide

Updated Category News Views 28

A Tsunami of Gratitude from Schools Nationwide The gesture is as vast as the nation's gratitude. To see 30,000 student letters flooding into the hands of veterans and active-duty service members is nothing short of overwhelming. This initiative by the National Heritage Academies (NHA) isn't just a token annual ritual—it's a profound statement of appreciation, showing...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative ForeSight Launch by Rocktop Technologies Transforms Management

Updated Category News Views 428

Introduction to ForeSight by Rocktop Technologies Rocktop Technologies has unveiled an impressive new solution named ForeSight, which aims to revolutionize the foreclosure management process. This groundbreaking tool addresses increasing challenges in the mortgage sector, especially during periods of rising delinquencies. The launch coincides with many mortgage servicers...

Continue Reading
Bracco Unveils New Facility to Boost Ultrasound Contrast Agent Production

Updated Category News Views 187

Bracco's Major Investment in Ultrasound Technology The recent investment oversaw the construction of a new facility dedicated to CEUS microbubble production. This innovative imaging platform, a product of Bracco's dedicated research, supports healthcare professionals worldwide in providing more precise diagnoses. As a result, it significantly enhances the overall quality...

Continue Reading
Innovative AI Tool Transforms Home Inspections with Convenience

Updated Category News Views 225

Transforming Home Inspections with AI Technology In a groundbreaking collaboration, Nationwide has joined forces with Chrp, an innovative AI-based home risk platform. This partnership introduces a revolutionary approach to home inspections, enabling homeowners to identify potential hazards using their smartphones. By leveraging advanced technology, this new program helps...

Continue Reading
CalciMedica's Auxora Trial Yields Hope for Acute Pancreatitis

Updated Category News Views 208

CalciMedica's Promising Results in Acute Pancreatitis Treatment CalciMedica Inc. (NASDAQ:CALC), a trailblazing biopharmaceutical company, has recently unveiled positive findings from its Phase 2b CARPO trial focusing on Auxora and its effect on acute pancreatitis (AP) alongside systemic inflammatory response syndrome (SIRS). The data, showcased at the recent American...

Continue Reading
5G Chipsets Market Growth Projected to Exceed $132 Billion

Updated Category News Views 90

Overview of 5G Chipsets Market Growth The 5G chipsets market is projected to exceed USD 132 billion, fueled by the rapid increase in connected devices and the growth of IoT applications. As both businesses and individuals continue to embrace smart technology, the demand for reliable communication solutions becomes increasingly important. 5G technology meets this demand by...

Continue Reading